Intraperitoneal 1.5% Delflex improves intestinal blood flow in necrotizing enterocolitis

Area of Science:

• Neonatal physiology
• Gastrointestinal research
• Vascular biology

Background:

• Necrotizing enterocolitis (NEC) impairs intestinal microvascular function, leading to vasoconstriction.
• Previous studies showed intraperitoneal 2.5% dextrose increased intestinal perfusion in NEC models.
• This study investigates if a buffered 1.5% dextrose solution with lower glucose and osmolar loads can improve intestinal blood flow.

Purpose of the Study:

• To determine if topical buffered 1.5% dextrose solution increases ileal blood flow in a rat model of NEC.
• To compare the efficacy of a lower concentration dextrose solution with previous findings.

Main Methods:

• Pregnant Sprague-Dawley rats were assigned to control or NEC groups.
• NEC was induced using established methods; control pups were dam-fed.
• Laser Doppler flowmetry measured terminal ileum perfusion at various time points after topical 1.5% dextrose application.

Main Results:

• Baseline ileal blood flow increased with gestational age in both groups.
• Control groups exhibited higher baseline blood flow than NEC groups.
• Topical 1.5% dextrose significantly increased blood flow compared to baseline in both groups across all time points.

Conclusions:

• Topical 1.5% dextrose solution enhanced terminal ileum blood flow similarly to 2.5% dextrose.
• Buffered 1.5% dextrose may be a more beneficial treatment for clinical NEC due to reduced glucose and osmotic stress.
• This approach warrants further investigation for NEC management.